Aurelien Delluc
Associate Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Research Interests
Dr. Delluc’s research program focuses on improving the diagnosis, treatment, and long-term management of venous thromboembolism (VTE). His work centers on conducting pragmatic, international randomized trials that go beyond anticoagulation to explore novel strategies such as cancer screening, statin therapy, and bleeding risk mitigation. Dr. Delluc is particularly committed to fostering innovation in thrombosis research through mentoring, interdisciplinary collaboration, and patient engagement.
Brief Biography
Dr. Aurélien Delluc is a clinician-scientist and a Faculty of Medicine, Department of Medicine, OHRI, Tier 1 Research Chair in Innovative Strategies in Venous Thromboembolism at the Ottawa Hospital Research Institute and a Full Professor in the Department of Medicine at the University of Ottawa. After training in France and completing a PhD focused on common risk factors between arterial and venous thromboembolism, Dr. Delluc moved to Canada in 2018 to join the Division of Hematology and Thrombosis. He brings a translational vision to his clinical and academic work, integrating evidence-based medicine, randomized trials, and population-level data to improve patient outcomes in thrombosis care.
Selected Publications
Diseases, conditions and populations of interest
Research and clinical approaches
